These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 32773261)

  • 1. SARS-CoV 2 and the pathobiology of the respiratory control mechanisms in the brainstem.
    Mishra R; Florez-Perdomo WA; Vasquez HE; Moscote-Salazar LR; Agrawal A
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 3):767-768. PubMed ID: 32773261
    [No Abstract]   [Full Text] [Related]  

  • 2. Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung.
    Bulfamante G; Bocci T; Falleni M; Campiglio L; Coppola S; Tosi D; Chiumello D; Priori A
    J Neurol; 2021 Dec; 268(12):4486-4491. PubMed ID: 34003372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19.
    Baig AM
    ACS Chem Neurosci; 2020 Aug; 11(16):2416-2421. PubMed ID: 32600045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrapulmonary SARS-CoV-2 manifestations.
    Carvalho T
    Nat Med; 2020 Dec; 26(12):1806. PubMed ID: 33288941
    [No Abstract]   [Full Text] [Related]  

  • 5. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.
    Hui KPY; Cheung MC; Perera RAPM; Ng KC; Bui CHT; Ho JCW; Ng MMT; Kuok DIT; Shih KC; Tsao SW; Poon LLM; Peiris M; Nicholls JM; Chan MCW
    Lancet Respir Med; 2020 Jul; 8(7):687-695. PubMed ID: 32386571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Silent" Presentation of Hypoxemia and Cardiorespiratory Compensation in COVID-19.
    Bickler PE; Feiner JR; Lipnick MS; McKleroy W
    Anesthesiology; 2021 Feb; 134(2):262-269. PubMed ID: 32970134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory Virus Infections: Understanding COVID-19.
    Subbarao K; Mahanty S
    Immunity; 2020 Jun; 52(6):905-909. PubMed ID: 32497522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Risk Factors for the Duration of Severe Acute Respiratory Syndrome Coronavirus 2 Viral Positivity in Patients With Coronavirus Disease 2019.
    Lin A; He ZB; Zhang S; Zhang JG; Zhang X; Yan WH
    Clin Infect Dis; 2020 Nov; 71(16):2061-2065. PubMed ID: 32337591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease.
    Dolan ME; Hill DP; Mukherjee G; McAndrews MS; Chesler EJ; Blake JA
    Sci Rep; 2020 Nov; 10(1):20848. PubMed ID: 33257774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin as candidate for supportive treatment of severe COVID-19.
    Ehrenreich H; Weissenborn K; Begemann M; Busch M; Vieta E; Miskowiak KW
    Mol Med; 2020 Jun; 26(1):58. PubMed ID: 32546125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extraction-free SARS-CoV-2 detection by rapid RT-qPCR universal for all primary respiratory materials.
    Lübke N; Senff T; Scherger S; Hauka S; Andrée M; Adams O; Timm J; Walker A
    J Clin Virol; 2020 Sep; 130():104579. PubMed ID: 32795959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical performance and sample freeze-thaw stability of the cobas®6800 SARS-CoV-2 assay for the detection of SARS-CoV-2 in oro-/nasopharyngeal swabs and lower respiratory specimens.
    Stohr JJJM; Wennekes M; van der Ent M; Diederen BMW; Kluytmans-van den Bergh MFQ; Bergmans AMC; Kluytmans JAJW; Pas SD
    J Clin Virol; 2020 Dec; 133():104686. PubMed ID: 33221622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19.
    Baig AM; Sanders EC
    ACS Chem Neurosci; 2020 Jun; 11(12):1701-1703. PubMed ID: 32469504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells.
    Stelzig KE; Canepa-Escaro F; Schiliro M; Berdnikovs S; Prakash YS; Chiarella SE
    Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1280-L1281. PubMed ID: 32432918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients.
    Flehmig B; Schindler M; Ruetalo N; Businger R; Bayer M; Haage A; Kirchner T; Klingel K; Normann A; Pridzun L; Tougianidou D; Ranke MB
    Viruses; 2020 Nov; 12(12):. PubMed ID: 33260809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of dysregulated immune responses in COVID-19 pathogenesis.
    Tahaghoghi-Hajghorbani S; Zafari P; Masoumi E; Rajabinejad M; Jafari-Shakib R; Hasani B; Rafiei A
    Virus Res; 2020 Dec; 290():198197. PubMed ID: 33069815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance Training Safety during and after the SARS-Cov-2 Outbreak: Practical Recommendations.
    Gentil P; de Lira CAB; Souza D; Jimenez A; Mayo X; de Fátima Pinho Lins Gryschek AL; Pereira EG; Alcaraz P; Bianco A; Paoli A; Papeschi J; Carnevali Junior LC
    Biomed Res Int; 2020; 2020():3292916. PubMed ID: 33029503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abrupt Deterioration of COVID-19 Patients and Spreading of SARS COV-2 Virions in the Lungs.
    Filipovic N; Saveljic I; Hamada K; Tsuda A
    Ann Biomed Eng; 2020 Dec; 48(12):2705-2706. PubMed ID: 33140243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of SARS-CoV-2 viral RNA in fecal samples.
    Mesoraca A; Margiotti K; Viola A; Cima A; Sparacino D; Giorlandino C
    Virol J; 2020 Jun; 17(1):86. PubMed ID: 32605577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge.
    Liang L; Yang B; Jiang N; Fu W; He X; Zhou Y; Ma WL; Wang X
    J Korean Med Sci; 2020 Dec; 35(47):e418. PubMed ID: 33289374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.